XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Redeemable Noncontrolling Interest
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Treasury stock
Retained Earnings
Beginning balance at Apr. 29, 2023 $ 941.8   $ 18.6 $ 181.0 $ (19.0) $ (11.5) $ 772.7
Beginning balance (in shares) at Apr. 29, 2023     37,167,375        
Beginning balance at Apr. 29, 2023   $ 11.1          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of restricted stock, net of tax withholding (3.8)   $ 0.1 (0.1)     (3.8)
Issuance of restricted stock, net of tax withholding (in shares)     255,120        
Cancellation of restricted stock 0.0   $ (0.1) 0.1      
Cancellation of restricted stock (in shares)     (144,000)        
Purchase of redeemable noncontrolling interest   $ (11.1)          
Purchases of common stock $ (10.8)   $ (0.2)       (10.6)
Purchases of common stock (in shares) (453,371)   (453,371)        
Stock-based compensation expense $ 0.7     0.7      
Other comprehensive income (loss) (12.2)       (12.2)    
Net loss (66.0)           (66.0)
Dividends on common stock (14.7)           (14.7)
Ending balance at Jan. 27, 2024 835.0   $ 18.4 181.7 (31.2) (11.5) 677.6
Ending balance (in shares) at Jan. 27, 2024     36,825,124        
Beginning balance at Oct. 28, 2023 844.9   $ 18.5 183.8 (42.9) (11.5) 697.0
Beginning balance (in shares) at Oct. 28, 2023     37,034,050        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of restricted stock, net of tax withholding (in shares)     65,666        
Cancellation of restricted stock     $ (0.1) 0.1      
Cancellation of restricted stock (in shares)     (144,000)        
Purchases of common stock $ (3.0)           (3.0)
Purchases of common stock (in shares) (130,592)   (130,592)        
Stock-based compensation expense $ (2.2)     (2.2)      
Other comprehensive income (loss) 11.7       11.7    
Net loss (11.6)           (11.6)
Dividends on common stock (4.8)           (4.8)
Ending balance at Jan. 27, 2024 835.0   $ 18.4 181.7 (31.2) (11.5) 677.6
Ending balance (in shares) at Jan. 27, 2024     36,825,124        
Beginning balance at Apr. 27, 2024 766.0   $ 18.3 183.6 (36.7) (11.5) 612.3
Beginning balance (in shares) at Apr. 27, 2024     36,650,909        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of restricted stock, net of tax withholding (3.3)   $ 0.3 (0.1)     (3.5)
Issuance of restricted stock, net of tax withholding (in shares)     568,698        
Cancellation of restricted stock (in shares)     (79,325)        
Conversion of cash bonus to RSUs 2.1     2.1      
Purchases of common stock $ (1.6)   $ (0.1)       (1.5)
Purchases of common stock (in shares) (136,000)   (136,000)        
Stock-based compensation expense $ 4.6     4.6      
Other comprehensive income (loss) (14.5)       (14.5)    
Net loss (34.3)           (34.3)
Dividends on common stock (14.7)           (14.7)
Ending balance at Feb. 01, 2025 704.3   $ 18.5 190.2 (51.2) (11.5) 558.3
Ending balance (in shares) at Feb. 01, 2025     37,004,282        
Beginning balance at Nov. 02, 2024 738.3   $ 18.3 188.6 (37.7) (11.5) 580.6
Beginning balance (in shares) at Nov. 02, 2024     36,621,507        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of restricted stock, net of tax withholding (3.0)   $ 0.2 (0.2)     (3.0)
Issuance of restricted stock, net of tax withholding (in shares)     382,775        
Purchases of common stock $ 0.0            
Purchases of common stock (in shares) 0            
Stock-based compensation expense $ 1.8     1.8      
Other comprehensive income (loss) (13.5)       (13.5)    
Net loss (14.4)           (14.4)
Dividends on common stock (4.9)           (4.9)
Ending balance at Feb. 01, 2025 $ 704.3   $ 18.5 $ 190.2 $ (51.2) $ (11.5) $ 558.3
Ending balance (in shares) at Feb. 01, 2025     37,004,282